Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The number to beat is 39%CR...(for now).

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Jan 07, 2024 8:58pm

189 Views

Post# 35814959

RE:RE:RE:RE:The number to beat is 39%CR...(for now).

It's easier now to see why many here are so wound up and unable to have rational conversations. It is much easier to dream up and project 20,000% to 30,000% gains and then protect that balloon from being popped by real questions around finances and timelines, for example. When we get to $5, let's talk. We'll have a happy starting point.

99942Apophis wrote: That 40B would be for the perfect dream of NMIBC, MIBC, vaccine, GBM & NSCLC giving us a share price of $125.00, realistically a $40 to $60 range isn't out of the question. I know some of my fellow posters might roll their eyes but this is highly possible!

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?